VRRM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Verra Mobility Corp (VRRM) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock shows bearish technical indicators, mixed analyst sentiment, and lacks significant positive catalysts to justify immediate entry. While the company has strong revenue growth and stable recurring revenue, its declining margins, EPS, and net income raise concerns. Additionally, no proprietary trading signals or significant insider/congress trading activity support a buy decision. A hold is recommended until better entry points or stronger catalysts emerge.
The technical indicators for VRRM are bearish. The MACD histogram is negative and expanding, RSI is neutral at 32.77, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 16.257), with resistance at 17.617. The pre-market price is $16.95, suggesting limited upside potential in the short term.
Revenue growth of 16% YoY in Q4 2025, driven by strong performance in the Government Solutions segment.
Positive market response to earnings release, with shares rising 2%.
Stable recurring revenue and market leadership in its segment.
Declining net income (-128.32% YoY) and EPS (-129.27% YoY) in Q4
Gross margin dropped by 4.57% YoY.
Analysts have lowered price targets, citing medium-term margin pressures and weaker Q1 performance due to temporary weather impacts.
Bearish technical indicators and lack of significant insider or hedge fund trading activity.
In Q4 2025, Verra Mobility reported revenue of $257.9 million, up 16.42% YoY. However, net income dropped to $18.88 million (-128.32% YoY), and EPS fell to $0.12 (-129.27% YoY). Gross margin also declined to 77.84% (-4.57% YoY). The company projects 2026 revenue between $1.02 billion and $1.03 billion, with adjusted EBITDA of $405-$415 million and free cash flow of $150-$160 million.
Analysts have mixed ratings on VRRM. JPMorgan, Deutsche Bank, Morgan Stanley, and Baird have all lowered price targets, citing weaker Q1 performance and medium-term margin pressures. Ratings range from Neutral to Buy, with price targets between $20 and $26, indicating limited upside from the current price of $16.95.
